Healthcare provider profile · identity verified

Farrokh Alemzadeh, MD

Internal Medicine · IRVINE, CA · NPI 1528094828

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	709	196
Atorvastatin Calcium	Atorvastatin Calcium	371	99
Losartan Potassium	Losartan Potassium	369	96
Levothyroxine Sodium	Levothyroxine Sodium	343	85
Amlodipine Besylate	Amlodipine Besylate	281	81
Fluticasone Propionate	Fluticasone Propionate	265	86
Metformin Hcl Er	Metformin Hcl	250	67
Famotidine	Famotidine	235	64
Vascepa	Icosapent Ethyl	217	39
Tamsulosin Hcl	Tamsulosin Hcl	215	66
Omeprazole	Omeprazole	195	61
Gabapentin	Gabapentin	182	51
Metoprolol Succinate	Metoprolol Succinate	180	52
Jardiance	Empagliflozin	156	39
Baclofen	Baclofen	126	52
Diclofenac Sodium	Diclofenac Sodium	126	60
Ezetimibe	Ezetimibe	124	39
Escitalopram Oxalate	Escitalopram Oxalate	118	32
Furosemide	Furosemide	118	34
Meloxicam	Meloxicam	117	43
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	114	32
Lisinopril	Lisinopril	111	33
Trazodone Hcl	Trazodone Hcl	110	29
Finasteride	Finasteride	107	38
Memantine Hcl	Memantine Hcl	105	29
Metformin Hcl	Metformin Hcl	102	29
Albuterol Sulfate Hfa	Albuterol Sulfate	100	32
Trulicity	Dulaglutide	94	16
Metoprolol Tartrate	Metoprolol Tartrate	93	23
Sertraline Hcl	Sertraline Hcl	93	25
Potassium Chloride	Potassium Chloride	92	33
Valsartan	Valsartan	87	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	84	43
Januvia	Sitagliptin Phosphate	83	20
Montelukast Sodium	Montelukast Sodium	83	33
Bupropion Xl	Bupropion Hcl	81	24
Citalopram Hbr	Citalopram Hydrobromide	79	16
Glipizide Er	Glipizide	78	24
Ibandronate Sodium	Ibandronate Sodium	76	29
Memantine Hcl Er	Memantine Hcl	76	20
Alendronate Sodium	Alendronate Sodium	75	21
Duloxetine Hcl	Duloxetine Hcl	75	19
Oxybutynin Chloride Er	Oxybutynin Chloride	69	22
Pantoprazole Sodium	Pantoprazole Sodium	66	23
Pravastatin Sodium	Pravastatin Sodium	66	16
Eliquis	Apixaban	65	16
Mirtazapine	Mirtazapine	65	20
Clonazepam	Clonazepam	61	11
Icosapent Ethyl	Icosapent Ethyl	59	23
Allopurinol	Allopurinol	58	14
Triamcinolone Acetonide	Triamcinolone Acetonide	58	29
Fluoxetine Hcl	Fluoxetine Hcl	54	11
Ketoconazole	Ketoconazole	54	16
Linzess	Linaclotide	54	12
Rivastigmine	Rivastigmine	53	16
Celecoxib	Celecoxib	52	21
Clopidogrel	Clopidogrel Bisulfate	51	14
Carvedilol	Carvedilol	49	14
Atenolol	Atenolol	48	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	13
Praluent Pen	Alirocumab	43	suppressed
Simvastatin	Simvastatin	43	11
Trijardy Xr	Empaglifloz/Linaglip/Metformin	43	suppressed
Breo Ellipta	Fluticasone/Vilanterol	42	15
Ozempic	Semaglutide	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	12
Myrbetriq	Mirabegron	41	suppressed
Raloxifene Hcl	Raloxifene Hcl	41	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	40	suppressed
Pregabalin	Pregabalin	39	14
Propranolol Hcl	Propranolol Hcl	39	11
Alprazolam	Alprazolam	38	11
Xarelto	Rivaroxaban	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	27
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Tramadol Hcl	Tramadol Hcl	35	16
Hydrochlorothiazide	Hydrochlorothiazide	34	11
Synthroid	Levothyroxine Sodium	33	suppressed
Lorazepam	Lorazepam	32	suppressed
Ondansetron Odt	Ondansetron	31	18
Lidocaine	Lidocaine	30	11
Nitroglycerin	Nitroglycerin	30	22
Azithromycin	Azithromycin	29	24
Fenofibrate	Fenofibrate,micronized	29	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	13
Donepezil Hcl	Donepezil Hcl	27	11
Telmisartan	Telmisartan	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Levofloxacin	Levofloxacin	25	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Alogliptin	Alogliptin Benzoate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Cephalexin	Cephalexin	20	18
Methylprednisolone	Methylprednisolone	20	14
Clotrimazole	Clotrimazole	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Mupirocin	Mupirocin	18	14
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Synjardy Xr	Empagliflozin/Metformin Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Ciclopirox	Ciclopirox	17	13
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Estradiol	Estradiol	16	suppressed
Glipizide	Glipizide	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Amoxicillin	Amoxicillin	15	13
Colchicine	Colchicine	15	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	15	suppressed
Prednisone	Prednisone	15	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	14	suppressed
Restasis	Cyclosporine	14	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Prolia	Denosumab	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error